58
Participants
Start Date
March 28, 2018
Primary Completion Date
July 20, 2019
Study Completion Date
July 20, 2019
Minocycline
Minocycline is a semisynthetic derivative of tetracycline and is indicated for the treatment of infections due to susceptible isolates of designated microorganisms.
Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham
Duke University Hospital - Duke Medicine Pavilion - MICU, Durham
Emory Decatur Hospital - Clinical Trials - Immunology/Infectious Disease, Decatur
University of Kentucky - UK Albert B Chandler Hospital, Lexington
University of Cincinnati College of Medicine - Division of Infectious Diseases, Cincinnati
Northwestern Medicine - Department of Obstetrics and Gynecology - Division of Female Pelvic Medicine and Reconstructive Surgery, Chicago
Oregon Health and Science University - Division of Pulmonary and Critical Care Medicine, Portland
Northwestern Memorial Hospital - ICU, Chicago
University of Louisville School of Medicine - Surgery, Louisville
Henry Ford Health System - Henry Ford Hospital, Detroit
William Beaumont Hospital - Royal Oak Campus - Infectious Disease, Royal Oak
Washington University School of Medicine in St. Louis - Infectious Diseases, St Louis
East Carolina University - Infectious Diseases and Tropical/Travel Medicine Clinic, Greenville
Case Western Reserve University School of Medicine - Medicine - Infectious Diseases and HIV Medicine, Cleveland
University of Pittsburgh - Medicine - Infectious Diseases, Pittsburgh
National Institute of Allergy and Infectious Diseases (NIAID)
NIH